AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 214 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $48,132,000 | +51.1% | 900,000 | 0.0% | 0.78% | -6.0% |
Q1 2020 | $31,860,000 | -25.9% | 900,000 | 0.0% | 0.83% | -2.8% |
Q4 2019 | $42,975,000 | +30596.4% | 900,000 | +350.0% | 0.85% | +21250.0% |
Q1 2019 | $140,000 | -99.3% | 200,000 | -20.0% | 0.00% | -99.3% |
Q1 2018 | $20,445,000 | – | 250,000 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,710,061 | $67,074,010 | 1.80% |
Bellevue Group AG | 4,013,500 | $99,334,125 | 1.60% |
Eagle Health Investments LP | 267,630 | $6,623,843 | 1.46% |
ARMISTICE CAPITAL, LLC | 3,324,000 | $82,269,000 | 1.26% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $11,236,500 | 0.61% |
Frazier Life Sciences Management, L.P. | 292,002 | $7,227,050 | 0.48% |
ArrowMark Colorado Holdings LLC | 1,573,359 | $38,940,635 | 0.47% |
Deep Track Capital, LP | 422,247 | $10,450,613 | 0.40% |
FARALLON CAPITAL MANAGEMENT LLC | 2,750,829 | $68,083,018 | 0.34% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 24,000 | $593,520 | 0.20% |